Drew Scott, PhD

Drew is a cancer biologist interested in identifying and targeting metabolic vulnerabilities in tumors. He joined the team after completing his doctoral research studying how mitochondria regulate cell death and survival. In the Wahl and Lyssiotis Labs, he is using in vivo systems to study how metabolic pathways protect brain tumors from radiation therapy and targeting these pathways in patients.

Hobbies: Lake life, running, reading, gaming, road trips